Ultima Genomics Platform Selected for Precure's One Million Sample Dataset
Ultima Genomics said in a press release that its UG200 Ultra Sequencing Platform was selected for Precure, an initiative led by Mayo Clinic with Thermo Fisher Scientific. The project will generate data from one million biospecimens, combining whole genome sequencing and proteomic information with clinical data collected over several years.
Helix will serve as the multiomics laboratory and AI tools provider. It will operate a fleet of UG200 platforms to produce sequencing data, while Precure will use AI and large scale data analysis to identify patterns associated with disease.
Ultima says each UG200 Ultra platform can produce up to 60,000 whole genomes annually. The system includes Solaris 2.0 Chemistry, paired end sequencing, and a pangenome aligner under development with NVIDIA and Google DeepVariant.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly, Enterprise AI Brief or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 11 Optum and Alameda Alliance Partner on AI Claims Automation Nov 11 Mosaic Raises $47M for Blood Vessel Surgery Robots Nov 11 Kardi AI Raises €5.3 Million for Heart Monitoring Expansion Nov 11 Switchpoint Bio raises $5.3 million for AI epigenomics platform Nov 10 Google Cloud Launches Gemini for Healthcare With HCA, Northwell and OptumMore from Enterprise
Nov 11 Optum and Alameda Alliance Partner on AI Claims Automation Nov 11 INVE Technologies Partners With Trackonomy on Physical AI Software Nov 11 Cerillion 26.2 Adds AI Agents and Churn Prediction Nov 11 Parloa and OpenAI Expand Customer Service AI Partnership Nov 11 Vodacom Seeks Partners for African AI Data CentresEnterprise AI Brief
Weekly report on AI business applications, enterprise software releases, automation tools, and industry implementations.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Illumina Launches BioInsight Platform for Genomic Research
Illumina Adds Three Research Tools to BioInsight Platform
INmune Bio and QCi Apply Quantum Computing to XPro Research
Radical Numerics Launches Omnii-1 Biology Model
Flagship Pioneering Merges Three Biotech Platforms Into Etcelera
Daily AI Brief: the AI news that matters, in your inbox.